Classen M Demling L Endoskopishe shinkterotomie der papilla Vateri und Stein extraction aus dem Duktus Choledochus [German] Dtsch Med Wochenschr 1974 99 496-497 
Kawai K Akasaka Y Murakami K Endoscopic sphincterotomy of the ampulla of Vater Gastrointest Endosc 1974 20 148-151 
Sohma S Takekawa I Okamoto Y Matsuda T Ono M Aoyagi T Endoscopic papillotomy: a new approach for extraction of residual stones Gastroenterol Endosc 1974 16 446-452 
Ikeda S Tanaka M Matsumoto S Yoshimoto H Itoh H Endoscopic sphincterotomy: Long-term results in 408 patients with complete follow-up Endoscopy 1988 20 13-17 
Cotton PB Lehman G Vennes J Geenen JE Russell RCG Meyers WC Endoscopic sphincterotomy complications and their management: an attempt at consensus Gastrointest Endosc 1991 37 383-393 
Rabenstein T Schneider TH Hahn EG Ell C 25&#160;years of endoscopic sphincterotomy in Erlangen: assessment of experience in 3,498 patients Endoscopy 1998 30 A194-A201 
Gerke H Baillie J To cut or stretch? Am J Gastroenterol 2004 99 1461-1463 
DiSario JA Freeman ML Bjorkman DJ MacMathuna P Petersen BT Jaffe PE Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones Gastroenterology 2004 127 1291-1299 
Tsujino T Isayama H Komatsu Y Ito Y Toda M Minagawa N Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation Am J Gastroenterol 2005 100 38-42 
Watanabe H Yoneda M Tominaga K Monma T Kanke K Shimada T Comparison between endoscopic papillary balloon dilation and endoscopic sphincterotomy for the treatment of common bile duct stones J Gastroenterol 2007 42 56-62 
Freeman ML Nelson DB Sherman S Haber GB Herman ME Complications of endoscopic biliary sphincterotomy N Engl J Med 1996 335 909-918 
Boender J Nix GA Ridder MA Blankenstein M Sch&#252;tte HE Dees J Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate Endoscopy 1994 26 209-216 
Staritz M Ewe K Meyer KH Endoscopic papillary dilation (EPD) for the treatment of common bile duct stones and papillary stenosis Endoscopy 1983 15 197-198 
Bader M Geenen JE Hogan WJ Dodds WJ Venu R Johnson GK Endoscopic balloon dilatation of the sphincter of Oddi in patients with suspected biliary dyskinesia; results of a prospective randomized trial Gastrointest Endosc 1986 32 AB158 
Kozarek RA Balloon dilation of the sphincter of Oddi Endoscopy 1988 20 207-210 
May GR Cotton PB Edmunds SE Chong W Removal of stones from the bile duct at ERCP without sphincterotomy Gastrointest Endosc 1993 39 749-754 
MacMathuna P White P Clarke E Lennon J Crowe J Endoscopic sphincteroplasty: a novel and safe alternative to papillotomy in the management of bile duct stones Gut 1994 35 127-129 
MacMathuna P White P Clarke E Merriman R Lennon JR Crowe J Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients Gastrointest Endosc 1995 42 468-474 
Bergman JJGH Rauws EAJ Fockens P Berkel A-M Bossuyt PM Tijssen JGP Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones Lancet 1997 349 1124-1129 
Komatsu Y Kawabe T Toda N Ohashi M Isayama H Tateishi K Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases Endoscopy 1998 30 12-17 
DiSario JA Freeman JL Bjorkman DJ MacMathuna P Peterson B Sherman S Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: preliminary results Gastrointest Endosc 1997 45 AB129 
DiSario JA Freeman JL Bjorkman DJ MacMathuna P Peterson B Sherman S Endoscopic balloon dilation vs sphincterotomy (EDES) bile duct stone removal Digestion 1999 59 Suppl 3 26 
DiSario JA Endoscopic balloon dilation of the sphincter of Oddi for stone extraction in the elderly: is the juice worth the squeeze? Gastrointest Endosc 2008 68 483-486 
Sato H Kodama J Takaaki J Tatsumi Y Maeda T Fijita Y Endoscopic papillary balloon dilatation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry Gut 1997 41 541-544 
Sugiyama M Atomi Y Long-term effects of endoscopic papillary balloon dilation on gallbladder motility Dig Dis Sci 2004 49 1803-1807 
Isayama H Komatsu Y Inoue Y Toda N Shiratori Y Tsujino T Preserved function of the Oddi sphincter after endoscopic papillary balloon dilation Hepatogastroenterology 2003 50 1787-1791 
Yasuda I Tomita E Enya M Kato T Moriwaki H Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function? Gut 2001 49 686-691 
Gregg JA Girolami P Carr Locke DL Effects of sphincteroplasty and endoscopic sphincterotomy on the bacteriologic characteristics of the common bile duct Am J Surg 1985 149 668-671 
Sand J Airo I Hiltunen KM Mattila J Nordback I Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy Am Surg 1992 58 324-328 
Greenfield C Cleland P Dick R Masters S Summerfield JA Sherlock S Biliary sequelae of endoscopic sphincterotomy Postgrad Med J 1985 61 213-215 
Kurumado K Nagai T Kondo Y Abe H Long-term observations on morphological changes of choledochal epithelium after choledochoenterostomy in rats Dig Dis Sci 1994 39 809-820 
MacMathuna P Siegenberg D Gibbons D Gorin D O&#8217;Brien M Afdehal NA The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs Gastrointest Endosc 1996 44 650-655 
Weinberg BM Shindy W Lo S Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones Cochrane Database Syst Rev 2006 4 CD004890 
Ito Y Tsujino T Togawa O Yamamoto N Isayama H Nakata R Endoscopic papillary balloon dilation for the management of bile duct stones in patients 85&#160;years of age and older Gastrointest Endosc 2008 68 477-482 
Toda N Saito K Wada R Kawabe T Shiratori Y Mitsushima T Omata M Endoscopic sphincterotomy and papillary balloon dilation for bile duct stones Hepatogastroenterology 2005 52 700-704 
Bergman JJGHM Berkel A-M Bruno MJ Fockens P Rauws EAJ Tijssen JGP A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy Gastrointest Endosc 2001 53 19-26 
Ochi Y Mukawa K Kiyosawa K Akamatsu T Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones J Gastroenterol Hepatol 1999 14 90-96 
Nakagawa H Ohara K Safeguards against acute pancreatitis associated with endoscopic papillary balloon dilation J Hepatobiliary Pancreat Surg 2006 13 75-79 
Tsujino T Kawabe T Isayama H Sasaki T Kogure H Togawa O Arisumi T Efficacy and safety of low-pressured and short-term dilation in endoscopic papillary balloon dilation for bile duct stone removal J Gastroenterol Hepatol 2008 23 867-871 
Vlavianos P Chopra K Mandalia S Anderson M Thompson J Westaby D Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial Gut 2003 52 1165-1169 
Natsui M Narisawa R Motoyama H Hayashi S Seki K Wakabayashi H What is an appropriate indication for endoscopic papillary balloon dilation? Eur J Gastroenterol Hepatol 2002 14 635-640 
Sugiyama M Abe N Izumisato Y Masaki T Mori T Atomi Y Risk factors for acute pancreatitis after endoscopic papillary balloon dilation Hepatogastroenterology 2003 50 1796-1798 
Minami A Nakatsu T Uchida N Hirabayashi S Fukuma H Morshed SA Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones Dig Dis Sci 1995 40 2550-2554 
Fujita N Maguchi H Komatsu Y Yasuda I Hasebe O Igarashi Y Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial Gastrointest Endosc 2003 57 151-155 
Tanaka S Sawayama T Yoshioka T Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial Gastrointest Endosc 2004 59 614-618 
Arnold JC Benz C Martin WR Adamek HE Riemann JF Endoscopic papillary balloon dilation vs sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study Endoscopy 2001 33 563-567 
Bergman JJ Tytgat GN Huibregtse K Endoscopic dilatation of the biliary sphincter for removal of bile duct stones: an overview of current indication and limitations Scand J Gastroenterol Suppl 1998 225 59-65 
Baron TH Harewood GC Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a meta analysis of randomized, controlled trials Am J Gastroenterol 2004 99 1455-1460 
Ersoz G Tekesin O Ozutemiz AO Gunsar F Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract Gastrointest Endosc 2003 57 156-159 
Bang S Kim MH Park JY Park SW Song SY Chung JB Endoscopic papillary balloon dilation with large balloon after limited sphincterotomy for retrieval of choledocholithiasis Yonsei Med J 2006 47 805-810 
Minami A Hirose S Nomoto T Hayakawa S Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy World J Gastroenterol 2007 13 2179-2182 
Heo JH Kang DH Jung HJ Kwon DS An JK Kim BS Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones Gastrointest Endosc 2007 66 720-726 
Attasaranya S Cheon YK Vittal H Howell DA Wakelin DE Cunningham JT Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series Gastrointest Endosc 2008 67 1046-1052 
Kochhar R Dutta U Shukla R Nagi B Singh K Wig JD Sequential endoscopic papillary balloon dilatation following limited sphincterotomy for common bile duct stones Dig Dis Sci 2009 54 1578-1581 
Itoi T Itokawa F Sofuni A Kurihara T Tsuchiya T Ishii K Endoscopic sphincterotomy combined with large balloon dilation can reduce the procedure time and fluoroscopy time for removal of large bile duct stones Am J Gastroenterol 2009 104 560-565 
Misra SP Dwivedi M Large-diameter balloon after endoscopic sphincterotomy for removal of difficult bile duct stones Endoscopy 2008 40 209-213 
Maydeo A Bhandari S Balloon sphincteroplasty for removing difficult bile duct stones Endoscopy 2007 39 958-961 
Brown BV Feener DH Behavior and host location cues of Apocephalus paraponera (Diptera: Phoridae), a parasitoid of the giant tropical ant, Paraponera clavata (Hymenoptera: Formicidae) Biotropica 1991 23 182-187 
Chen L Sharma KR Fadamiro HY Fire ant venom alkaloids act as key attractants for the parasitic phorid fly, Pseudacteon tricuspis (Diptera: Phoridae) Naturwissenschaften 2009 96 1421-1429 
C&#244;nsoli FL Wuellner CT Vinson SB Gilbert LE Immature development of Pseudacteon tricuspis (Diptera: Phoridae), an endoparasitoid of the red imported fire ant (Hymenoptera: Formicidae) Ann Entomol Am 2001 94 97-109 
Do Nascimento RR Billen J Stant&#8217;ana AEG Morgan ED Harada AY Pygidial gland of Azteca NR. bicolor and Azteca chartifex: Morphology and chemical identification of volatile components J Chem Ecol 1998 24 1629-1637 
Feener DH Competition between ant species-outcome controlled by parasitic flies Science 1981 214 815-817 
Feener DH Size selective oviposition in Pseudacteon crawfordi (Diptera: Phoridae), a parasite of fire ants Ann Entom Soc Am 1987 80 148-151 
Feener DH Brown BV Reduced foraging of Solenopsis geminata (Hymenoptera: Formicidae) in the presence of parasitic Pseudacteon spp. (Diptera: Phoridae) Ann Entomol Soc Am 1992 85 80-84 
Feener DH Jacobs LF Schmidt JO Specialized parasitoid attracted to a pheromone of ants Anim Behav 1996 51 61-66 
Gazal V Bailez O Viana-Bailez AM Mechanism of host recognition in Neodohrniphora elongata (Brown) (Diptera: Phoridae) Anim Behav 2009 78 1177-1182 
Gilbert LE Morrison LW Patterns of host specificity in Pseudacteon parasitoid flies (Diptera: Phoridae) that attack Solenopsis Fire ants (Hymenoptera: Formicidae) Environ Entomol 1997 26 1149-1154 
H&#246;lldobler B Multimodal signals in ant communication J Comput Phys A 1999 184 129-141 
Jackson BD Morgan ED Insect chemical communication: pheromones and exocrine glands of ants Chemoecology 1993 4 125-144 
LeBrun EG Feener DH Linked indirect effects in ant-phorid interactions: impacts on ant assemblage structure Oecologia 2002 133 599-607 
Lin BB Agroforestry management as an adaptive strategy against potential microclimate extremes in coffee agriculture Agric For Meteorol 2007 144 85-94 
Maschwitz UA Weissflog A Seebaur S Disney R Witte V Studies on European ant decapitating flies (Diptera: Phoridae): I. Releasers and phenology of parasitism of Psuedacteon formicarum Sociobiol 2008 51 127-140 
Moorehead SA Feener DH Visual and chemical cues used in host location and acceptance by a dipteran parasitoid J Insect Behav 2000 14 613 
Morrison LW Gilbert LE Host specificity in two additional Pseudacteon spp. (Diptera: Phoridae), parasitoids of Solenopsis fire ants (Hymenoptera: Formicidae) Fla Entomol 1999 82 404-409 
Morrison LW King JR Host location behavior in a parasitoid of imported fire ants J Insect Behav 2004 17 367-383 
Morrison LW Porter SD Post-release host-specificity testing of Pseudacteon tricuspis, a phorid parasitoid of Solenopsis invicta fire ants Biocontrol 2006 51 195-205 
Orr MR Parasitic flies (Diptera: Phoridae) influence foraging rhythms and caste division of labor in the leaf-cutter ant, Atta cephalotes (Hymenoptera: Formicidae) Behav Ecol Sociobiol 1992 30 395-402 
Orr MR Seike SH Benson WW Gilbert LE Flies suppress fire ants Nature 1995 373 292-293 
Orr MR Camargo RE Benson WW Interactions between ant species increase arrival rates of an ant parasitoid Anim Behav 2003 65 1187-1193 
Owens ED Prokopy RJ Relationship between reflectance spectra of host plant surfaces and visual detection of host fruit by Rhgoletis promonella flies Phys Entomol 1986 11 297-307 
Partan SR Marler P Issues in the classification of multimodal communication signals Am Nat 2002 166 231-245 
Perfecto I Vandermeer J The effect of an ant-hemipteran mutualism on the coffee berry borer (Hypothenemus hampei) in southern Mexico Agric Ecosyst Environ 2006 117 218-221 
Philpott SM Ant patchiness: a spatially quantitative test in coffee agroecosystems Naturwissenschaften 2005 93 386-392 
Philpott SM Trail-mediated effects of parasitic phorid flies (Diptera: Phoridae) on ant (Hymenoptera: Formicidae) competition and resource access in coffee agroecosystems Environ Entomol 2005 24 1089-1094 
Philpott SM Maldonado J Vandermeer J Perfecto I Taking tropic cascades up a level: behaviorally-modified effects of phorid flies on ants and ant prey in coffee agroecosystems Oikos 2004 105 141-147 
Plowes RM LeBrun EG Brown BV Gilbert LE A Review of Pseudacteon (Diptera: Phoridae) that parasitize ants of the Solenopsis geminata complex (Hymenoptera: Formicidae) Ann Entomol Soc Am 2009 102 937-958 
Porter SD Biology and behavior of Pseudacteon decapitating flies (Diptera: Phoridae) that parasitize Solenopsis fire ants (Hymenoptera: Formicidae) Fla Entomol 1998 81 292-309 
Porter SD Fowler HG Campiolo S Pesquero MA Host specificity of several Pseudacteon (Diptera: Phoridae) parasites of fire ants (Hymenoptera: Formicidae) in South America Fla Entomol 1995 78 70-75 
Puckett RT Calixto A Barr CL Harris M Sticky traps for monitoring Pseudacteon parasitoids of Solenopsis fire ants Environ Entomol 2007 36 584-588 
Vandermeer J Perfecto I Nu&#241;ez GI Philpott SM Ballinas AG Ants (Azteca sp.) as potential biological control agents in shade coffee production in Chiapas, Mexico Agroforest Syst 2002 56 271-276 
Ross J Jr Braunwald E Morrow A Left heart catheterization by the transseptal route: a description of the technic and its applications Circulation 1960 22 927-934 
Brockenbrough EC Braunwald E Ross J Jr Transseptal left heart catheterization. A review of 450 studies and description of an improved technic Circulation 1962 25 15-21 
Ross J Jr Transseptal left heart catheterization a 50-year odyssey Journal of the American College of Cardiology 2008 51 2107-2115 
Earley MJ How to perform a transseptal puncture Heart 2009 95 85-92 
Gaita F Caponi D Pianelli M Scaglione M Toso E Cesarani F Boffano C Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation Circulation 2010 122 1667-1673 
Sangiorgi G Colombo A Distal protection devices Heart Sep 2003 89 990-992 
Biam DS Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts Circulation 2002 105 1285 
Stone GW Rogers C Hermiller J Feldman R Hall P Haber R Masud A Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts Circulation 2003 108 548-553 
Smelley MP Shah DP Weisberg I Kim SS Lin AC Beshai JF Burke MC Knight BP Initial experience using a radiofrequency powered transseptal needle Journal of Cardiovascular Electrophysiology 2010 21 423-427 
Wong CW Ruygrok P Sutton T Ding P Vliet C Occleshaw C Smith W Transseptal fine needle aspiration of a large left atrial tumour Heart, Lung &amp; Circulation 2010 19 438-439 
Maleki K Mohammadi R Hart D Cotiga D Farhat N Steinberg JS Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention Journal of Cardiovascular Electrophysiology 2005 16 561-565 
Romero-Rodriguez N Pedrote A Arana-Rueda E Mogollon-Jimenez MV Thrombus development on a transseptal sheath in the right atrium before electrical pulmonary vein isolation Indian Pacing and Electrophysiology Journal 2008 8 72-74 
CMR. Chemical Profile. Hydrofluoric Acid. Chemical Market Reporter, October 7, 2002.
ATSDR Toxicological Profile for Fluorides, Hydrogen Fluoride, and Fluorine 2003 Atlanta, GA Agency for Toxic Substances and Disease Registry Available at:
China, People's Republic of. Press Release. August 19, 2008
Anderson W.J. Anderson J.R. Hydrofluoric acid burns of the hand: mechanism of injury and treatment J. Hand Surg. Am. 1988 13 52-57 
McCulley J.P. Whiting D.W. Petitt M.G. Lauber S.E. Hydrofluoric acid burns of the eye J. Occup. Med. 1983 25 447-450 
Matsumoto S. [Hydrofluoric acid burn: particulars on multiple pulmonary thrombi] J.UOEH 1989 11 411-424 
Mayer L. Guelich J. Hydrogen fluoride (HF) inhalation and burns Arch. Environ. Health 1963 7 445-447 
Braun J. St&#246;ss H. Zober A. Intoxication following the inhalation of hydrogen fluoride Arch. Toxicol. 1984 56 50-54 
Makarovsky I. Markel G. Dushnitsky T. Eisenkraft A. Hydrogen fluoride&#8212;the protoplasmic poison Isr. Med. Assoc. J. 2008 10 381-385 
Murao M. Studies on the treatment of hydrofluoric acid burn Bull. Osaka Med. Coll. 1989 35 39-48 
Mayer T.G. Gross P.L. Fatal systemic fluorosis due to hydrofluoric acid burns Ann. Emerg. Med. 1985 14 149-153 
Chan K.M. Svancarek W.P. Creer M. Fatality due to acute hydrofluoric acid exposure J. Toxicol. Clin. Toxicol. 1987 25 333-339 
Mullett T. Zoeller T. Bingham H. Pepine C.J. Prida X.E. Castenholz R. Kirby R. Fatal hydrofluoric acid cutaneous exposure with refractory ventricular fibrillation J. Burn Care Rehabil. 1987 8 216-219 
Sheridan R.L. Ryan C.M. Quinby W.C. Jr Blair J. Tompkins R.G. Burke J.F. Emergency management of major hydrofluoric acid exposures Burns 1995 21 62-64 
MacKinnon M.A. Hydrofluoric acid burns Dermatol. Clin. 1988 6 67-74 
Yoshida Y. Watanabe M. Shimada M. Kurimoto K. [Effect of hydrofluoric-acid burn on glucose metabolism] Nippon Eiseigaku Zasshi 1975 30 145 
Kono K. Yoshida Y. Harada A. Watanabe M. Hirota T. Tanimura Y. Shibuya Y. An experimental study on the biochemical consequences of hydrofluoric acid burns Bull. Osaka Med. Sch. 1982 28 124-133 
Klauder J.V. Shelanski L. Gabriel K. Industrial uses of compounds of fluorine and oxalic acid; cutaneous reaction and calcium therapy AMA. Arch. Ind. Health 1955 12 412-419 
Upfal M. Doyle C. Medical management of hydrofluoric acid exposure J. Occup. Med. 1990 32 726-731 
Matsuno K. The treatment of hydrofluoric acid burns Occup. Med. (Lond). 1996 46 313-317 
Dalamaga M. Karmaniolas K. Nikolaidou A. Papadavid E. Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury J. Burn Care Res. 2008 29 541-543 
Hult&#233;n P. H&#246;jer J. Ludwigs U. Janson A. Hexafluorine vs. standard decontamination to reduce systemic toxicity after dermal exposure to hydrofluoric acid J. Toxicol. Clin. Toxicol. 2004 42 355-361 
Takase I. Kono K. Tamura A. Nishio H. Dote T. Suzuki K. Fatality due to acute fluoride poisoning in the workplace Leg. Med. (Tokyo). 2004 6 197-200 
Segal E.B. First aid for a unique acid, HF: a sequel J. Chem. Health Saf. 2000 7 18-23 
Burke W.J. Hoegg U.R. Phillips R.E. Systemic fluoride poisoning resulting from a fluoride skin burn J. Occup. Med. 1973 15 39-41 
D&#252;nser M.W. Ohlbauer M. Rieder J. Zimmermann I. Ruatti H. Schwabegger A.H. Bodrogi F. Huemer G.M. Friesenecker B.E. Mayr A.J. Lirk P. Critical care management of major hydrofluoric acid burns: a case report, review of the literature, and recommendations for therapy Burns 2004 30 391-398 
Mathieu L. Nehles J. Blomet J. Hall A.H. Efficacy of Hexafluorine for emergent decontamination of hydrofluoric acid eye and skin splashes Vet. Human Toxicol. 2002 44 52-53 
H&#246;jer J. Personne M. Hult&#233;n P. Ludwigs U. Topical treatments for hydrofluoric acid burns: a blind controlled experimental study J. Toxicol. Clin. Toxicol. 2002 40 861-866 
Ohtani M. Nishida N. Chiba T. Muto H. Yoshioka N. Pathological demonstration of rapid involvement into the subcutaneous tissue in a case of fatal hydrofluoric acid burns Forensic Sci. Int. 2007 167 49-52 
Th&#233;nard, Gay Lussac. M&#233;moire sur l'acide fluorhydrique Annales de Chimie, Acad&#233;mie Royale des Sciences de l'Institut Fran&#231;ais 1809 
Tepperman P.N. Fatality due to acute systemic fluoride poisoning following a hydrofluoric acid skin burn J. Occup. Med. 1980 22 691-692 
Gallerani M. Bettoli V. Peron L. Manfredini R. Systemic and topical effects of intradermal hydrofluoric acid Am. J. Emerg. Med. 1998 16 521-522 
Trap R. Christensen I. [Hydrofluoric acid injuries: pathogenesis and treatment] Ugeskr. Laeg. 1990 152 1570-1572 
Vance M.V. Curry S.C. Kunkel D.B. Ryan P.J. Ruggeri S.B. Digital hydrofluoric acid burns: treatment with intraarterial calcium infusion Ann. Emerg. Med. 1986 15 890-896 
Segal E.B. First aid for a unique acid: HF Segal Consults 2000 2701 Liberty Street, Easton, PA 18405-2620 
Honeywell Documentation First Aid Treatment for Hydrofluoric Acid Burns. Available at:
Schrage N.F. Rihawi R. Frentz M. Reim M. [Acute therapy for eye burns] Klin. Monbl. Augenheilkd. 2004 221 253-261 
Hall A.H. Maibach H.I. Water decontamination of chemical skin/eye splashes: a critical review Cutan. Ocul. Toxicol. 2006 25 67-83 
Eyer F. Zilker T. [Caustic injuries of the eye, skin and the gastrointestinal tract] Ther. Umsch. 2009 66 379-386 
Soderberg K. Kuusinen P. Mathieu L. Hall A.H. An improved method for emergent decontamination of ocular and dermal hydrofluoric acid splashes Vet. Hum. Toxicol. 2004 46 216-218 
Blunt C.P. Treatment of hydrofluoric acid skin burns by injection with calcium gluconate Ind. Med. Surg. 1964 33 869-871 
Thomas D. Jaeger U. Sagoschen I. Lamberti C. Wilhelm K. Intra-arterial calcium gluconate treatment after hydrofluoric acid burn of the hand Cardiovasc. Intervent. Radiol. 2009 32 155-158 
Nguyen L.T. Mohr W.J. 3rd Ahrenholz D.H. Solem L.D. Treatment of hydrofluoric acid burn to the face by carotid artery infusion of calcium gluconate J. Burn Care Rehabil. 2004 25 421-424 
Mistry D.G. Wainwright D.J. Hydrofluoric acid burns Am. Fam. Physician 1992 45 1748-1754 
Siegel D.C. Heard J.M. Intra-arterial calcium infusion for hydrofluoric acid burns Aviat. Space. Environ. Med. 1992 63 206-211 
Graudins A. Burns M.J. Aaron C.K. Regional intravenous infusion of calcium gluconate for hydrofluoric acid burns of the upper extremity Ann. Emerg. Med. 1997 30 604-607 
Achinger R. K&#246;hnlein H.E. Jacobitz K. [A new treatment method of hydrofluoric acid burns of the extremities] Chir. Forum Exp. Klin. Forsch. 1979 229-231 
Williams J.M. Hammad A. Cottington E.C. Harchelroad F.C. Intravenous magnesium in the treatment of hydrofluoric acid burns in rats Ann. Emerg. Med. 1994 23 464-469 
Heard K. Hill R.E. Cairns C.B. Dart R.C. Calcium neutralizes fluoride bioavailability in a lethal model of fluoride poisoning J. Toxicol. Clin. Toxicol. 2001 39 349-353 
Seyb S.T. Noordhoek L. Botens S. Mani M.M. A study to determine the efficacy of treatments for hydrofluoric acid burns J. Burn Care Rehabil. 1995 16 253-257 
Burkhart K.K. Brent J. Kirk M.A. Baker D.C. Kulig K.W. Comparison of topical magnesium and calcium treatment for dermal hydrofluoric acid burns Ann. Emerg. Med. 1994 24 9-13 
Cox R.D. Osgood K.A. Evaluation of intravenous magnesium sulfate for the treatment of hydrofluoric acid burns Ann. Emerg. Med. 1994 23 464-469 
Hatzifotis M. Williams A. Muller M. Pegg S. Hydrofluoric acid burns Burns 2004 30 156-159 
Kirkpatrick J.J. Burd D.A. An algorithmic approach to the treatment of hydrofluoric acid burns Burns 1995 21 495-499 
Ohata U. Hara H. Suzuki H. 7 cases of hydrofluoric acid burn in which calcium gluconate was effective for relief of severe pain Contact Dermatitis 2005 52 133-137 
Hall A.H. Blomet J. Gross M. Nehles J. Hexafluorine for emergent decontamination of hydrofluoric acid eye/skin splashes Semiconductor Saf. Assoc. J. 2000 14 30-33 
Haffner SM Abdominal adiposity and cardiometabolic risk: do we have all the answers? American Journal of Medicine 2007 120 9 S10-S16 
Posern G Treisman R Actin&#8217; together: serum response factor, its cofactors and the link to signal transduction Trends in Cell Biology 2006 16 11 588-596 
Pipes GCT Creemers EE Olson EN The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis Genes and Development 2006 20 12 1545-1556 
Zhang X Azhar G Chai J Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor American Journal of Physiology&#8212;Heart and Circulatory Physiology 2001 280 4 H1782-H1792 
Parlakian A Charvet C Escoubet B Temporally controlled onset of dilated cardiomyopathy through disruption of the srf gene in adult heart Circulation 2005 112 19 2930-2939 
Zhang X Azhar G Furr MC Zhong Y Wei JY Model of functional cardiac aging: young adult mice with mild overexpression of serum response factor American Journal of Physiology&#8212;Regulatory Integrative and Comparative Physiology 2003 285 3 R552-R560 
Azhar G Zhang X Wang S Zhong Y Quick CM Wei JY Maintaining serum response factor activity in the older heart equal to that of the young adult is associated with better cardiac response to isoproterenol stress Basic Research in Cardiology 2007 102 3 233-244 
Miano JM Role of serum response factor in the pathogenesis of disease Laboratory Investigation 2010 90 9 1274-1284 
Halberg N Wernstedt-Asterholm I Scherer PE The adipocyte as an endocrine cell Endocrinology and Metabolism Clinics of North America 2008 37 3 753-768 
Kim J-Y van de Wall E Laplante M Obesity-associated improvements in metabolic profile through expansion of adipose tissue Journal of Clinical Investigation 2007 117 9 2621-2637 
Deckelbaum RJ Worgall TS Seo T n-3 fatty acids and gene expression American Journal of Clinical Nutrition 2006 83 6 p. 1520S 
Neschen S Morino K Rossbacher JC Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-&#947;-dependent mechanism in mice Diabetes 2006 55 4 924-928 
Banga A Unal R Tripathi P Adiponectin translation is increased by the PPAR&#947; agonists pioglitazone and &#969;-3 fatty acids American Journal of Physiology&#8212;Endocrinology and Metabolism 2009 296 3 E480-E489 
Rodbell M Metabolism of isolated fat cells. I. Effects of hormone on glucose metabolism and lipolysis Journal of Biological Chemistry 1964 239 375-380 
Saffari B Ong JM Kern PA Regulation of adipose tissue lipoprotein lipase gene expression by thyroid hormone in rats Journal of Lipid Research 1992 33 2 241-249 
Green H Meuth M An established pre adipose cell line and its differentiation in culture Cell 1974 3 2 127-133 
Chang J Wei L Otani T Youker KA Entman ML Schwartz RJ Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading Circulation 2003 108 4 407-413 
Pajvani UB Du X Combs TP Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: implications for metabolic regulation and bioactivity Journal of Biological Chemistry 2003 278 11 9073-9085 
Unal R Yao-Borengasser A Varma V Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone Journal of Clinical Endocrinology and Metabolism 2010 95 6 2993-3001 
Itoh M Suganami T Satoh N Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 9 1918-1925 
Rasouli N Yao-Borengasser A Miles LM Elbein SC Kern PA Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression American Journal of Physiology&#8212;Endocrinology and Metabolism 2006 290 1 E42-E46 
Bodles AM Banga A Rasouli N Ono F Kern PA Owens RJ Pioglitazone increases secretion of high-molecular-weight adiponectin from adipocytes American Journal of Physiology&#8212;Endocrinology and Metabolism 2006 291 5 E1100-E1105 
Abbasi F Chu JW Lamendola C Discrimination between obesity and insulin resistance in the relationship with adiponectin Diabetes 2004 53 3 585-590 
Tao L Gao E Jiao X Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress Circulation 2007 115 11 1408-1416 
Gauthier-Rouviere C Vandromme M Tuil D Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts Molecular Biology of the Cell 1996 7 5 719-729 
Sakuma K Akiho M Nakashima H Akima H Yasuhara M Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles Biochimica et Biophysica Acta 2008 1782 7-8 453-461 
Be&#322;towski J Jamroz-Wi&#347;niewska A Widomska S Adiponectin and its role in cardiovascular diseases Cardiovascular and Hematological Disorders&#8212;Drug Targets 2008 8 1 7-46 
Inoue T Kotooka N Morooka T High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease American Journal of Cardiology 2007 100 4 569-574 
Duncan BB Schmidt MI Pankow JS Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 2004 53 9 2473-2478 
Valentine RC Valentine DL Omega-3 fatty acids in cellular membranes: a unified concept Progress in Lipid Research 2004 43 5 383-402 
Shibata R Sato K Pimentel DR Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms Nature Medicine 2005 11 10 1096-1103 
Amari SI Beltrame F Bjaalie JG Neuroinformatics: the integration of shared databases and tools towards integrative neuroscience J. Integr. Neurosci. 2002 1 117-128 
Anderson JR Jones BW Yang J-H A computational framework for ultrastructural mapping of neural circuitry PLoS Biol. 2009 7 e1000074 
Fiala JC Reconstruct: a free editor for serial section microscopy J. Microsc. 2005 218 52-61 
Gansner ER North SC An open graph visualization system and its applications to software engineering Softw. &#8211; Pract. Exp. 1999 30 1203-1233 
Google KML Reference &#8211; KML &#8211; Google Code 2010 Google, Inc 
Kasai H Matsuzaki M Noguchi J Yasumatsu N Nakahara H Structure-stability-function relationships of dendritic spines Trends Neurosci. 2003 26 360-368 
Kolb H Famiglietti EV Rod and cone pathways in the inner plexiform layer of cat retina Science (Washington, DC) 1975 186 47-49 
Marc RE Jones BW Molecular phenotyping of retinal ganglion cells J. Neurosci. 2002 22 412-427 
Martone ME Tran J Wong WW The cell centered database project: an update on building community resources for managing and sharing 3D imaging data J. Struct. Biol. 2008 161 220-231 
Mikula S Trotts I Stone JM Jones EG Internet-enabled high-resolution brain mapping and virtual microscopy Neuroimage 2007 35 9-15 
Mishchenko Y Automation of 3D reconstruction of neural tissue from large volume of conventional serial section transmission electron micrographs J. Neurosci. Methods 2009 176 276-289 
Mungall C Misra S Berman B An integrated computational pipeline and database to support whole-genome sequence annotation Genome Biol. 2002 3 0081.0081-0081.0011 research
NASA, JPL-Caltech &amp; Microsoft 2010 NASA Be A Martian
Schawinski K Lintott C Thomas D Galaxy Zoo: a sample of blue early-type galaxies at low redshift Mon. Not. Royal Astron. Soc. 2009 396 1-18 
Sheng M Hoogenraad CC The postsynaptic architecture of excitatory synapses: a more quantitative view Annu. Rev. Biochem. 2007 76 823-847 
Strettoi E Dacheux RF Raviola E Synaptic connections of the rod bipolar cells in the inner plexiform layer of the rabbit retina J. Comp. Neurol. 1990 295 449-466 
Strettoi E Raviola E Dacheux RF Synaptic connections of the narrow-field, bistratified rod amacrine cell (AII) in the rabbit retina J. Comp. Neurol. 1992 325 152-168 
Hunter T Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling Cell 1995 80 225-236 
Songyang Z Carraway KL 3rd Eck MJ Harrison SC Feldman RA Mohammadi M Schlessinger J Hubbard SR Smith DP Eng C Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Nature 1995 373 536-539 
Shah K Liu Y Deirmengian C Shokat KM Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates Proc Natl Acad Sci USA 1997 94 3565-3570 
Burnett G Kennedy EP The enzymatic phosphorylation of proteins J Biol Chem 1954 211 969-980 
Du J Lei B Qin J Liu H Yao X Molecular modeling studies of vascular endothelial growth factor receptor tyrosine kinase inhibitors using QSAR and docking J Mol Graph Model 2009 27 642-654 
Rossi KA Markwalder JA Seitz SP Chang CH Cox S Boisclair MD Brizuela L Brenner SL Stouten PF Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors J Comput Aided Mol Des 2005 19 111-122 
Perez PC Caceres RA Canduri F Filgueira de Azevedo JW Molecular modeling and dynamics simulation of human cyclin-dependent kinase 3 complexed with inhibitors Comput Biol Med 2009 39 130-140 
Ravindra GK Achaiah G Sastry GN Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking Eur J Med Chem 2008 43 830-838 
Talele TT McLaughlin ML Molecular docking/dynamics studies of Aurora A kinase inhibitors J Mol Graph Model 2008 26 1213-1222 
Chen XM Lu T Lu S Li HF Yuan HL Ran T Liu HC Chen YD Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors J Mol Model 2009 16 1195-1204 
Schaftenaar G Noordik JH Molden: a pre- and post-processing program for molecular and electronic structures J Comput Aided Mol Des 2000 14 1231-1234 
Gruszczy&#324;ski P Ka&#378;mierkiewicz R Obuchowski M Lammek B Theoretical modeling of PrkCc, serine-threonine protein kinase intracellular domain, complexed with ATP derivatives QSAR Comb Sci 2007 27 437-444 
Case DA Cheatham TE 3rd Darden T Gohlke H Luo R Merz KM Jr Onufriev A Simmerling C Wang B Woods RJ The Amber biomolecular simulation programs J Comput Chem 2005 26 1668-1688 
Schmidt M Baldridge K Boatz J Elbert S Gordon M Jensen J Koseki S Matsunaga N Nguyen K Su S Windus T Dupuis M Montgomery J General atomic and molecular electronic structure system J Comput Chem 1993 14 1347-1363 
Meagher KL Redman LT Carlson HA Development of polyphosphate parameters for use with the AMBER force field J Comput Chem 2003 24 1016-1025 
Williams NH Magnesium Ion Catalyzed ATP Hydrolysis J Am Chem Soc 2000 122 12023-12024 
Lin X Ayrapetov MK Sun G Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator BMC Biochem 2005 6 25 
Gruszczy&#324;ski P Obuchowski M Ka&#378;mierkiewicz R Phosphorylation and ATP-binding induced conformational changes in the PrkC Ser/Thr kinase from B. subtilis J Comput Aided Mol Des 2010 
Martinez L Laine E Malliavin TE Nilges M Blondel A ATP conformations and ion binding modes in the active site of anthrax edema factor: a computational analysis Proteins 2009 77 971-983 
Bashford D Case DA Generalized born models of macromolecular solvation effects Annu Rev Phys Chem 2000 51 129-152 
Pastor RW Brooks BR Szabo A An analysis of the accuracy of Langevin and molecular dynamics algorithms Mol Phys 1988 65 1409-1419 
Durand MD White SR Trading accuracy for speed in parallel simulated annealing with simultaneous moves Parallel Comput 2000 26 135-150 
Liu Y Shah K Yang F Witucki L Shokat KM Engineering Src family protein kinases with unnatural nucleotide specificity Chem Biol 1998 5 91-101 
Altona C Sundaralingam M Conformational analysis of the sugar ring in nucleosides and nucleotides J Am Chem Soc 1972 94 8205-8212 
Allen FH The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr B 2002 58 380-388 
Lin LZ Hu SF Cordell GA 19[alpha]-hydroxygelsamydine from Gelsemium elegans Phytochemistry 1996 43 723-726 
Wasserman HJ Ryan RR Layne SP Structure of acetanilide (C8H9NO) at 113&#160;K Acta Crystallogr C 1985 41 783-785 
Yang L Fang H Zheng H Weng LL (3S)-4-Phenyl-3-(phenylaminooxy)butan-2-one. Corrigendum Acta Cryst 2007 E63 e27 
Silversides JD Sparke AE Archibald SJ N-(4-Nitrobenzyl)benzene-1, 2-diamine Acta Cryst 2006 E62 o5944-o5946 
Hokelek T Kilic E Tuzun C Structural investigations of benzo[c]cinnoline derivatives. II. Structures of 2-pyrrolidinobenzo[c]cinnoline and 4 pyrrolidinobenzo[c]cinnoline Acta Crystallogr C 1991 47 373-376 
Liu X Kassiou M Christie MJ Hambley TW Trishomocubanes: requirements for &#945; receptor binding and subtype selectivity Aust J Chem 2001 54 31-36 
James BD Mutrofin S Skelton BW White AH 4-(piperidin-1-yl)pyridinium hexafluorophosphate at 150&#160;K Acta Crystallogr C 2003 59 o622-o624 
Aillon KL Xie YM El-Gendy N Berkland CJ Forrest ML Effects of nanomaterial physicochemical properties on in vivo toxicity Adv Drug Deliv Rev 2009 61 457-466 
Alivisatos AP Semiconductor clusters, nanocrystals, and quantum dots Science 1996 271 933-937 
Alkilany AM Murphy CJ Gold nanoparticles with a polymerizable surfactant bilayer: synthesis, polymerization, and stability evaluation Langmuir 2009 25 13874-13879 
Alkilany AM Frey RL Ferry JL Murphy CJ Gold nanorods as nanoadmicelles: 1-naphthol partitioning into a nanorod-bound surfactant bilayer Langmuir 2008 24 10235-10239 
Alkilany AM Nagaria PK Hexel CR Shaw TJ Murphy CJ Wyatt MD Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects Small 2009 5 701-708 
Anker JN Hall WP Lyandres O Shah NC Zhao J Duyne RP Biosensing with plasmonic nanosensors Nat Mater 2008 7 442-453 
AshaRani PV Mun GLK Hande MP Valiyaveettil S Cytotoxicity and genotoxicity of silver nanoparticles in human cells ACS Nano 2009 3 279-290 
Au L Zhang Q Cobley CM Quantifying the cellular uptake of antibody-conjugated Au nanocages by two-photon microscopy and inductively coupled plasma mass spectrometry ACS Nano 2010 4 35-42 
Ballou B Ernst LA Andreko S Sentinel lymph node imaging using quantum dots in mouse tumor models Bioconjug Chem 2007 18 389-396 
Bar-Ilan O Albrecht RM Fako VE Furgeson DY Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos Small 2009 5 1897-1910 
Bastus NG Sanchez-Tillo E Pujals S Peptides conjugated to gold nanoparticles induce macrophage activation Mol Immunol 2009 46 743-748 
Cedervall T Lynch I Foy M Detailed identification of plasma proteins adsorbed on copolymer nanoparticles Angew Chem Int Ed 2007 46 5754-5756 
Chen YS Hung YC Liau I Huang GS Assessment of the in vivo toxicity of gold nanoparticles Nanoscale Res Lett 2009 4 858-864 
Chithrani BD Chan WCW Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes Nano Lett 2007 7 1542-1550 
Chithrani BD Ghazani AA Chan WCW Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett 2006 6 662-668 
Cho EC Xie JW Wurm PA Xia YN Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant Nano Lett 2009 9 1080-1084 
Cho WS Cho MJ Jeong J Acute toxicity and pharmacokinetics of 13&#160;nm-sized PEG-coated gold nanoparticles Toxicol Appl Pharmacol 2009 236 16-24 
Cho EC Liu Y Xia Y A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures Angew Chem Int Ed 2010 49 1976-1980 
Choi HS Liu W Misra P Renal clearance of quantum dots Nat Biotechnol 2007 25 1165-1170 
Colvin VL The potential environmental impact of engineered nanomaterials Nat Biotechnol 2003 21 1166-1170 
Conner SD Schmid SL Regulated portals of entry into the cell Nature 2003 422 37-44 
Connor EE Mwamuka J Gole A Murphy CJ Wyatt MD Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity Small 2005 1 325-327 
Jong WH Hagens WI Krystek P Burger MC Sips AJAM Geertsma RE Particle size-dependent organ distribution of gold nanoparticles after intravenous administration Biomaterials 2008 29 1912-1919 
Dickerson EB Dreaden EC Huang XH Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice Cancer Lett 2008 269 57-66 
Dobrovolskaia MA McNeil SE Immunological properties of engineered nanomaterials Nat Nanotechnol 2007 2 469-478 
Dobrovolskaia MA Aggarwal P Hall JB McNeil SE Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution Mol Pharm 2008 5 487-495 
Dobrovolskaia MA Patri AK Zheng JW Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles Nanomedicine 2009 5 106-117 
Eghtedari M Oraevsky A Copland JA Kotov NA Conjusteau A Motamedi M High sensitivity of in vivo detection of gold nanorods using a laser optoacoustic imaging system Nano Lett 2007 7 1914-1918 
Eghtedari M Liopo AV Copland JA Oraevslty AA Motamedi M Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells Nano Lett 2009 9 287-291 
Fako VE Furgeson DY Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity Adv Drug Deliv Rev 2009 61 478-486 
Ferrari M Cancer nanotechnology: opportunities and challenges Nat Rev Cancer 2005 5 161-171 
Ferry JL Craig P Hexel C Transfer of gold nanoparticles from the water column to the estuarine food web Nat Nanotechnol 2009 4 441-444 
Finkelstein AE Walz DT Batista V Mizraji M Roisman F Misher A Auranofin: new oral gold compound for treatment of rheumatoid-arthritis Ann Rheum Dis 1976 35 251-257 
Fischer HC Chan WCW Nanotoxicity: the growing need for in vivo study Curr Opin Biotechnol 2007 18 565-571 
Gao HJ Shi WD Freund LB Mechanics of receptor-mediated endocytosis Proc Natl Acad Sci USA 2005 102 9469-9474 
Goodman CM McCusker CD Yilmaz T Rotello VM Toxicity of gold nanoparticles functionalized with cationic and anionic side chains Bioconjug Chem 2004 15 897-900 
Griffith LG Swartz MA Capturing complex 3D tissue physiology in vitro Nat Rev Mol Cell Biol 2006 7 211-224 
Grzelczak M Perez-Juste J Mulvaney P Liz-Marzan LM Shape control in gold nanoparticle synthesis Chem Soc Rev 2008 37 1783-1791 
Gu YJ Cheng JP Lin CC Lam YW Cheng SH Wong WT Nuclear penetration of surface functionalized gold nanoparticles Toxicol Appl Pharmacol 2009 237 196-204 
Han G Ghosh P Rotello VM Functionalized gold nanoparticles for drug delivery Nanomedicine 2007 2 113-123 
Hauck TS Ghazani AA Chan WCW Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells Small 2008 4 153-159 
Helmus M The need for rules and regulations Nat Nanotechnol 2007 2 333-334 
Hess H Tseng Y Active intracellular transport of nanopartides: opportunity or threat? ACS Nano 2007 1 390-392 
Hillyer JF Albrecht RM Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles J Pharm Sci 2001 90 1927-1936 
Hirsch LR Stafford RJ Bankson JA Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance Proc Natl Acad Sci USA 2003 100 13549-13554 
Jain PK Huang XH El-Sayed IH El-Sayed MA Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine Acc Chem Res 2008 41 1578-1586 
Jia HY Liu Y Zhang XJ Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum J Am Chem Soc 2009 131 40-41 
Kattumuri V Katti K Bhaskaran S Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies Small 2007 3 333-341 
Kelly KL Coronado E Zhao LL Schatz GC The optical properties of metal nanoparticles: the influence of size, shape, and dielectric environment J Phys Chem B 2003 107 668-677 
Khan JA Pillai B Das TK Singh Y Maiti S Molecular effects of uptake of gold nanoparticles in HeLa cells Chembiochem 2007 8 1237-1240 
Lal S Clare SE Halas NJ Nanoshell-enabled photothermal cancer therapy: impending clinical impact Acc Chem Res 2008 41 1842-1851 
Lee J Lilly GD Doty RC Podsiadlo P Kotov NA In vitro toxicity testing of nanoparticles in 3D cell culture Small 2009 5 1213-1221 
Leonov AP Zheng JW Clogston JD Stern ST Patri AK Wei A Detoxification of gold nanorods by treatment with polystyrenesulfonate ACS Nano 2008 2 2481-2488 
Lewinski N Colvin V Drezek R Cytotoxicity of nanoparticles Small 2008 4 26-49 
Liu YL Shipton MK Ryan J Kaufman ED Franzen S Feldheim DL Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers Anal Chem 2007 79 2221-2229 
Lynch I Dawson KA Protein-nanoparticle interactions Nano Today 2008 3 40-47 
Lynch I Cedervall T Lundqvist M Cabaleiro-Lago C Linse S Dawson KA The nanoparticle&#8211;protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century Adv Colloid Interface Sci 2007 134&#8211;135 167-174 
Marquis BJ Love SA Braun KL Haynes CL Analytical methods to assess nanoparticle toxicity Analyst 2009 134 425-439 
Maynard AD Aitken RJ Butz T Safe handling of nanotechnology Nature 2006 444 267-269 
Metz O Stoll W Plenert W Meningosis prophylaxis with intrathecal Au-198-colloid and methotrexate in childhood acute lymphocytic-leukemia Cancer 1982 49 224-228 
Murphy CJ San TK Gole AM Anisotropic metal nanoparticles: synthesis, assembly, and optical applications J Phys Chem B 2005 109 13857-13870 
Murphy CJ Sau TK Gole A Orendorff CJ Surfactant-directed synthesis and optical properties of one-dimensional plasmonic metallic nanostructures MRS Bull 2005 30 349-355 
Murphy CJ Gole AM Hunyadi SE Chemical sensing and imaging with metallic nanorods Chem Commun 2008 5 544-557 
Murphy CJ Gole AM Stone JW Gold nanoparticles in biology: beyond toxicity to cellular imaging Acc Chem Res 2008 41 1721-1730 
Nativo P Prior IA Brust M Uptake and intracellular fate of surface-modified gold nanoparticles ACS Nano 2008 2 1639-1644 
Nel A Xia T Madler L Li N Toxic potential of materials at the nanolevel Science 2006 311 622-627 
Niidome T Yamagata M Okamoto Y Akiyama Y Takahashi H Kawano T Katayama Y Niidome Y PEG-modified gold nanorods with a stealth character for in vivo applications J Control Release 2006 114 343-347 
Nikoobakht B El-Sayed MA Evidence for bilayer assembly of cationic surfactants on the surface of gold nanorods Langmuir 2001 17 6368-6374 
Norman RS Stone JW Gole A Murphy CJ Sabo-Attwood TL Targeted photothermal lysis of the pathogenic bacteria, Pseudomonas aeruginosa, with gold nanorods Nano Lett 2008 8 302-306 
Oberdorster G Sharp Z Atudorei V Translocation of inhaled ultrafine particles to the brain Inhal Toxicol 2004 16 437-445 
Ostrowski AD Martin T Conti J Hurt I Harthorn BH Nanotoxicology: characterizing the scientific literature, 2000&#8211;2007 J Nanopart Res 2009 11 251-257 
Pan Y Neuss S Leifert A Size-dependent cytotoxicity of gold nanoparticles Small 2007 3 1941-1949 
Pan Y Leifert A Ruau D Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage Small 2009 5 18 2067-2076 
Parng C In vivo zebrafish assays for toxicity testing Curr Opin Drug Discov Dev 2005 8 100-106 
Patra HK Banerjee S Chaudhuri U Lahiri P Dasgupta AK Cell selective response to gold nanoparticles Nanomedicine 2007 3 111-119 
Pernodet N Fang XH Sun Y Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts Small 2006 2 766-773 
Qian XM Peng XH Ansari DO Yin-Goen Q Chen GZ Shin DM Yang L Young AN Wang MD Nie SM In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags Nat Biotechnol 2008 26 83-90 
Rosi NL Mirkin CA Nanostructures in biodiagnostics Chem Rev 2005 105 1547-1562 
Rosi NL Giljohann DA Thaxton CS Lytton-Jean AKR Han MS Mirkin CA Oligonucleotide-modified gold nanoparticles for intracellular gene regulation Science 2006 312 1027-1030 
Ryan JA Overton KW Speight ME Cellular uptake of gold nanoparticles passivated with BSA-SV40 large T antigen conjugates Anal Chem 2007 79 9150-9159 
Sarin H Kanevsky AS Wu HT Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells J Transl Med 2008 6 1-15 
Sau TK Murphy CJ Seeded high yield synthesis of short Au nanorods in aqueous solution Langmuir 2004 20 6414-6420 
Shukla R Bansal V Chaudhary M Basu A Bhonde RR Sastry M Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview Langmuir 2005 21 10644-10654 
Skrabalak SE Chen JY Sun YG Gold nanocages: synthesis, properties, and applications Acc Chem Res 2008 41 1587-1595 
Sonavane G Tomoda K Makino K Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size Colloids Surf B 2008 66 274-280 
Stone JW Sisco PN Goldsmith EC Baxter SC Murphy CJ Using gold nanorods to probe cell-induced collagen deformation Nano Lett 2007 7 116-119 
Takahashi H Niidome Y Niidome T Kaneko K Kawasaki H Yamada S Modification of gold nanorods using phospatidylcholine to reduce cytotoxicity Langmuir 2006 22 2-5 
Tervonen T Linkov I Figueira JR Steevens J Chappell M Merad M Risk-based classification system of nanomaterials J Nanopart Res 2009 11 757-766 
Troutman TS Barton JK Romanowski M Biodegradable plasmon resonant nanoshells Adv Mater 2008 20 2604-2608 
Tsoli M Kuhn H Brandau W Esche H Schmid G Cellular uptake and toxicity of Au(55) clusters Small 2005 1 841-844 
Turner M Golovko VB Vaughan OPH Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters Nature 2008 454 U31-981 
Unfried K Albrecht C Klotz LO Mikecz A Grether-Beck S Schins RPF Cellular responses to nanoparticles: target structures and mechanisms Nanotoxicology 2007 1 52-71 
Verma A Uzun O Hu YH Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles Nat Mater 2008 7 588-595 
Vesaratchanon S Nikolov A Wasan DT Sedimentation in nano-colloidal dispersions: effects of collective interactions and particle charge Adv Colloid Interface Sci 2007 134&#8211;35 268-278 
Villiers CL Freitas H Couderc R Villiers MB Marche PN Analysis of the toxicity of gold nanoparticles on the immune system: effect on dendritic cell functions J Nanopart Res 2009 12 55-60 
Maltzahn G Park JH Agrawal A Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas Cancer Res 2009 69 3892-3900 
Weissleder R A clearer vision for in vivo imaging Nat Biotechnol 2001 19 316-317 
Willets KA Duyne RP Localized surface plasmon resonance spectroscopy and sensing Annu Rev Phys Chem 2007 58 267-297 
Yamada KM Cukierman E Modeling tissue morphogenesis and cancer in 3D Cell 2007 130 601-610 
Zhang GD Yang Z Lu W Zhang R Huang Q Tian M Li L Liang D Li C Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumorxenografted mice Biomaterials 2009 30 1928-1936 
Amiya T Bando H Brossi A Aconitum alkaloids The alkaloids 1988 San Diego Academic Press 95-179 
Joshi BS Pelletier SW Pelletier SW Recent developments in the chemistry of norditerpenoid and diterpenoid alkaloids Alkaloids: chemical and biological perspectives 1999 Amsterdam Pergamon 289-370 
Benn MH Jacyno JM Pelletier SW The toxicology and pharmacology of diterpenoid alkaloids Alkaloids: chemical and biological perspectives 1983 New York Wiley-Interscience 153-210 
Fu M Wu M Qiao Y Wang Z Toxicological mechanisms of Aconitum alkaloids Pharmazie 2006 61 735-741 
Wada K Ishizuki S Mori T Bando H Murayama M Kawahara N Effects of alkaloids from Aconitum yesoense var. macroyesoense on cutaneous blood flow in mice Biol Pharm Bull 1997 20 978-982 
Wada K Ishizuki S Mori T Fujihira E Kawahara N Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in mice Biol Pharm Bull 1998 21 140-146 
Wada K Ishizuki S Mori T Fujihira E Kawahara N Effects of Aconitum alkaloid kobusine and pseudokobusine derivatives on cutaneous blood flow in mice; II Biol Pharm Bull 2000 23 607-615 
Meng LH Zhang JS Ding J Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes Biochem Pharmacol 2001 62 733-741 
Qing C Jiang C Zhang JS Ding J Induction of apoptosis in human leukemia K-562 and gastric carcinoma SGC-7901 cells by salvicine, a novel anticancer compound Anticancer Drugs 2001 12 51-56 
Didelot C Mirjolet JF Barberi-Heyob M Ramacci C Merlin JL Radiation could induce p53-independent and cell cycle&#8212;unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells Can J Physiol Pharmacol 2002 80 638-643 
Baumann M Krause M Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results Radiother Oncol 2004 72 257-266 
Haveman J Castro-Kreder N Rodermond HM Bree C Franken NA Stalpers LJ Zdzienicka MZ Peters GJ Cellular response of X-ray sensitive hamster mutant cell lines to gemcitabine, cisplatin and 5-fluorouracil Oncol Rep 2004 12 187-192 
Sonnemann J Gekeler V Ahlbrecht K Brischwein K Liu C Bader P M&#252;ller C Niethammer D Beck JF Down-regulation of protein kinase C&#951; by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel Cancer Lett 2004 209 177-185 
Zhang M Boyer M Rivory L Hong A Clarke S Stevens G Fife K Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells Int J Radiat Oncol Biol Phys 2004 58 353-360 
Kvols LK Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets J Nucl Med 2005 46 187S-190S 
Pauwels B Korst AEC Andriessen V Baay MFD Pattyn GGO Lambrechts HAJ Pooter CMJ Lardon F Vermorken JB Unraveling the mechanism of radiosensitization by gemcitabine: the role of TP53 Radiat Res 2005 164 642-650 
Chodoeva A Bosc JJ Guillon J Decendit A Petraud M Absalon C Vitry C Jarry C Robert J 8-O-Azeloyl-14-benzoylaconine: a new alkaloid from the roots of Aconitum karacolicum Rapcs and its antiproliferative activities Bioorg Med Chem 2005 13 6493-6501 
In&#233;s C Reina M Gav&#237;n JA Gonz&#225;lez-Coloma A In vitro cytotoxicity of norditerpenoid alkaloids Z Naturforsch C 2006 61 11-18 
Wada K Hazawa M Takahashi K Mori T Kawahara N Kashiwakura I Inhibitory effects of diterpenoid alkaloids on the growth of A172 human malignant cells J Nat Prod 2007 70 1854-1858 
Hazawa M Wada K Takahashi K Mori T Kawahara N Kashiwakura I Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth Invest New Drugs 2009 27 111-119 
Wada K Bando H Amiya T Two new C20-diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (Nakai) Tamura. Structures of dehydrolucidusculine and N-deethyldehydrolucidusculine Heterocycles 1985 23 2473-2477 
Bando H Wada K Amiya T Kobayashi K Fujimoto Y Sakurai T Studies on Aconitum species V. Constituents of Aconitum yesoense var. macroyesoense (Nakai) Tamura Heterocycles 1987 26 2623-2637 
Wada K Bando H Kawahara N Studies on Aconitum species XIII. Two new diterpenoid alkaloids from Aconitum yesoense var. macroyesoense (Nakai) Tamura. VI Heterocycles 1990 31 1081-1088 
Ogura H Tsukumo Y Sugimoto H Igarashi M Nagai K Kataoka T ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide Int Immunopharmacol 2008 8 922-926 
Lee JW Min HY Han AR Chung HJ Park EJ Park HJ Hong JY Seo EK Lee SK Growth inhibition and induction of G1 phase cell cycle arrest in human lung cancer cells by a phenylbutenoid dimer isolated from Zingiber cassumunar Biol Pharm Bull 2007 30 1561-1564 
Nguyen TT Tran E Ong CK Lee SK Do PT Huynh TT Nguyen TH Lee JJ Tan Y Ong CS Huynh H Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK J Cell Physiol 2003 197 110-121 
Nakagawa M Oliva JL Kothapalli D Fournier A Assoian RK Kazanietz MG Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase C&#948;-dependent induction of p21 J Biol Chem 2005 280 33926-33934 
Franke A. Teyssen S. Harder H. Singer M. V. Effect of ethanol and some ethanolic beverages on gastric emptying in humans Scand J Gastroenterol 2004 7 39 7 638-644 
Freitas R. A. Nanomedicine, Volume 1: Basic capabilities 1999 Georgetown, TX Landes Bioscience 
HMP1013 A randomised, open-label, single dose, 4 way crossover study of the effects of varying doses of ethanol on the pharmacokinetic characteristics of 12 mg hydromorphone hydrochloride extended release capsules (Palladone&#8482;) in two groups (fed and fasted) of healthy volunteers Data in house, Purdue Pharma (US)
HMP1014 A randomised, open-label, single dose, 7-treatment, 4-period, Incomplete block crossover study in healthy male subjects to determine the effect of ethanol administration at varying times on the pharmacokinetics of hydromorphone hydrochloride (Palladone&#8482;)12 mg Data in house, Purdue Pharma (US)
Levitt M. D. Li R. Demaster E. G. Elson M. Furne J. Levitt D. G. Use of measurements of ethanol absorption from stomach and intestine to assess human ethanol metabolism Am J Physiol 1997 10 273 4 Pt 1 G951-G957 
Meyer R. J. Hussein A. S. Awareness Topic: Mitigating the risks of ethanol induced dose dumping from oral sustained/controlled release dosage forms FDA's ACPS Meeting October 2005 
Oneta C. M. Simanowski U. A. Martinez M. Allali-Hassani A. Pares X. Homann N. Conradt C. Waldherr R. Fiehn W. Courelle C. Seitz H. K. First pass metabolism of ethanol is strikingly influenced by the speed of gastric emptying Gut. 1998 11 43 5 612-619 
